Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Hancox

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Respirology (Carlton, Vic.)|February 12, 2024
Respiratory health effects of cannabis-How should we respond to liberalization of cannabis laws?Robert J Hancox
Clinical Reviews in Allergy & Immunology|November 7, 2006
Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesisRobert J Hancox
Annals of the American Thoracic Society|September 30, 2022
To β-Block or Not to β-Block: That Is Still the Question in Chronic Obstructive Pulmonary DiseaseRobert J Hancox
Respirology (Carlton, Vic.)|December 16, 2024
The commercial determinants of respiratory healthRobert J Hancox
Respirology (Carlton, Vic.)|July 14, 2025
Cheap, Convenient, and Quality Healthcare-Pick Any TwoRobert J Hancox
Respirology (Carlton, Vic.)|December 15, 2018
When is a confounder not a confounder?Robert J Hancox
Clinical Reviews in Allergy & Immunology|November 7, 2006
Interactions between corticosteroids and beta2-agonistsRobert J Hancox
Respirology (Carlton, Vic.)|August 24, 2020
Letter from New ZealandRobert J Hancox
The European Respiratory Journal|February 2, 2018
Does physical fitness enhance lung function in children and young adults?Robert J Hancox, Finn Rasmussen
Respiratory Research|March 8, 2007
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trialsSarah Haney, Robert J Hancox
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Respirology (Carlton, Vic.)|February 12, 2024
Respiratory health effects of cannabis-How should we respond to liberalization of cannabis laws?Robert J Hancox
Clinical Reviews in Allergy & Immunology|November 7, 2006
Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesisRobert J Hancox
Annals of the American Thoracic Society|September 30, 2022
To β-Block or Not to β-Block: That Is Still the Question in Chronic Obstructive Pulmonary DiseaseRobert J Hancox
Respirology (Carlton, Vic.)|December 16, 2024
The commercial determinants of respiratory healthRobert J Hancox
Respirology (Carlton, Vic.)|July 14, 2025
Cheap, Convenient, and Quality Healthcare-Pick Any TwoRobert J Hancox
Respirology (Carlton, Vic.)|December 15, 2018
When is a confounder not a confounder?Robert J Hancox
Clinical Reviews in Allergy & Immunology|November 7, 2006
Interactions between corticosteroids and beta2-agonistsRobert J Hancox
Respirology (Carlton, Vic.)|August 24, 2020
Letter from New ZealandRobert J Hancox
The European Respiratory Journal|February 2, 2018
Does physical fitness enhance lung function in children and young adults?Robert J Hancox, Finn Rasmussen
Respiratory Research|March 8, 2007
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trialsSarah Haney, Robert J Hancox
Pageof 17